Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)
NCT05238311
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Elranatamab
Sponsor
Pfizer